Study guide

Orbital infection and idiopathic inflammation

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Orbital infection and idiopathic inflammation

Key Takeaways Explain This Topic AI

Postseptal infection threatens vision and can spread intracranially, requiring urgent systemic treatment.

Visual decline, RAPD, entrapment or a collection changes the need for surgical assessment.

Idiopathic inflammation is a diagnosis requiring exclusion of infection and tumour; steroid response alone is insufficient.

Last updated: October 2026

Orbital Cellulitis vs. Preseptal Cellulitis

The orbital septum is a thin, fibrous sheet originating from the periosteum of the orbital rims (arcus marginale) and fusing with the retractor aponeurosis in the eyelids. It forms an essential physiological and anatomical barrier preventing superficial periorbital cutaneous infections from spreading into the deeper orbital space.

Clinical Differentiation

  • Clinical Parameter Preseptal (Periorbital) Cellulitis Orbital (Postseptal) Cellulitis
  • Anatomic Site Anterior to the orbital septum Posterior to the orbital septum (intraconal/extraconal)
  • Visual Acuity Normal (unimpaired) Reduced or threatened (DON, optic nerve compromise)
  • Pupillary Reflexes Normal; NO RAPD RAPD may be present (indicates optic neuropathy)
  • Ocular Motility Full, unrestricted ocular range Ophthalmoplegia ; painful, restricted ocular movement
  • Proptosis (Exophthalmos) Absent Present (cardinal sign of orbital volume expansion)
  • Pain Mild local tenderness of eyelid skin Severe deep orbital pain exacerbated by eye movements
  • Conjunctiva Mild injection; chemosis rare Marked chemosis , prolapse, and ciliary injection
  • Systemic Features Low-grade fever or afebrile High fever, leukocytosis, toxic appearance

Primary Route of Infection Skin laceration, insect bite, hordeolum Often contiguous spread from sinus infection, particularly ethmoid disease

Management Oral outpatient antibiotics (mild) Urgent hospital admission; stat IV broad-spectrum antibiotics

Caution

The presence of any one of the following five cardinal signs establishes a diagnosis of orbital cellulitis rather than preseptal cellulitis, transforming the case into a vision- and life-threatening ophthalmic emergency:

  • Proptosis (axial or non-axial globe displacement)
  • Ophthalmoplegia / restricted ocular motility
  • Pain exacerbated by ocular movement
  • Relative Afferent Pupillary Defect (RAPD) or loss of visual acuity
  • Severe conjunctival chemosis
  • Pathophysiology & Microbiology of Orbital Cellulitis

Pathogenesis: Orbital cellulitis often follows contiguous spread from adjacent sinus infection, particularly ethmoid sinusitis , especially in children; the distribution varies with age and setting. Bacteria traverse the thin, perforated lamina papyracea directly or travel along the valveless orbital ophthalmic venous plexuses and Breschet's diploic canals. Secondary causes include orbital trauma, retained wooden or organic foreign bodies, dacryocystitis, dental root abscesses, and septic bacteremic embolization.

Microbiology:

Streptococcus pneumoniae (most common in community-acquired sinus sources)

Staphylococcus aureus (including methicillin-resistant S. aureus [MRSA], particularly common after cutaneous trauma or surgical disruption)

Streptococcus pyogenes (Group A Strep)

Haemophilus influenzae type b (markedly reduced since conjugate vaccination, but still seen in unimmunized pediatric cohorts)

Polymicrobial Anaerobes ( Bacteroides , Peptostreptococcus , Fusobacterium ): Common in older children and adults with chronic dentoalveolar or multisinus disease.

Complications: Subperiosteal Abscess & Cavernous Sinus Thrombosis

Subperiosteal Abscess (SPA): A localized accumulation of purulent material between the periorbita (orbital periosteum) and the bony orbital wall, most frequently along the medial wall secondary to ethmoiditis. Periorbita acts as a tough mechanical barrier detaching from the bone.

Surgical Drainage Indications for SPA:

A large or non-medial abscess, concerning progression or inadequate source control; size, location and the overall clinical state inform the decision rather than one universal linear cutoff

  • Evidence of optic nerve compromise (decreased vision, RAPD, visual field loss)
  • Intracranial extension or co-existing frontal sinus abscess

Lack of clinical improvement or progressive deterioration within 24 to 48 hours of parenteral intravenous antibiotic therapy.

Cavernous Sinus Thrombosis (CST): Septic retrograde thrombosis extending via the superior and inferior ophthalmic veins into the cavernous sinus.

Cardinal Signs: Bilateralization of orbital signs (contralateral proptosis and chemosis), abducens (CN VI) nerve palsy as the earliest sign (due to its free-floating course in the center of the sinus adjacent to the carotid), rapid development of complete internal and external ophthalmoplegia (CN III, IV, VI), severe hypoesthesia in V 1 / V 2 V_1/V_2 V 1 ​ / V 2 ​ distributions, high-spiking septic fever, and altered consciousness. Carries high mortality.

Idiopathic Orbital Inflammatory Disease (IOID)

Idiopathic Orbital Inflammatory Disease (IOID), historically designated orbital pseudotumour , is a benign, non-granulomatous, non-infectious, fibro-inflammatory space-occupying lesion of the orbit characterized by a polymorphous lymphoplasmacytic infiltrate without identifiable local or systemic etiology.

Clinical Presentation & Subtypes

IOID characteristically presents in middle-aged adults with an abrupt, explosive onset of severe, deep orbital pain , marked periorbital oedema, proptosis, ptosis, and diplopia. The disease is typically unilateral, although bilateral presentation can occur (more common in pediatric patients, which mandates an exhaustive workup for systemic vasculitis, sarcoidosis, or lymphoma).

Anatomical subtypes include:

Orbital Myositis: Inflammation localized to one or more extraocular muscles (presenting with severe pain exacerbated by specific gaze movements).

Dacryoadenitis: Inflammation localized to the lacrimal gland (producing a classic S-shaped ptosis and tender superolateral orbital rim mass).

Anterior Orbital Inflammation: Involving the sclera (scleritis), Tenon's capsule, and anterior fat.

Apical Orbital Inflammation / Tolosa-Hunt Syndrome: Inflammatory infiltration of the orbital apex and superior orbital fissure / cavernous sinus, producing painful ophthalmoplegia and sensory loss along V 1 V_1 V 1 ​ .

CT/MRI patterns and their limitations

Neuroimaging provides the essential radiologic distinction between IOID (orbital myositis) and Thyroid Eye Disease:

IOID (Myositis): Diffuse inflammatory enlargement involving BOTH the extraocular muscle belly AND its anterior tendinous insertion onto the sclera. Associated with periorbital stranding, ragged muscle margins, and diffuse infiltration of the adjacent orbital fat.

Thyroid Eye Disease: Spindle-shaped, fusiform enlargement of the muscle belly with crisp sparing of the anterior tendon .

Management and the limits of steroid response

Systemic corticosteroids: After infection and relevant neoplasia have been assessed, selected IOI can be treated with systemic corticosteroids under specialist supervision. Response can be rapid, but is neither universal nor diagnostic; lymphoma can also improve temporarily. Taper and steroid-sparing treatment depend on phenotype, relapse and adverse effects.

Orbital Biopsy: Indicated if there is an atypical clinical presentation, palpable anterior mass, lack of immediate response to corticosteroids, rapid relapse during steroid tapering, or bony erosion on imaging, to exclude orbital lymphoma, IgG4-related ophthalmic disease, sarcoidosis, or Granulomatosis with Polyangiitis (GPA).

Comprehensive Diagnostic Differentiation: TED vs IOID vs Orbital Cellulitis

Diagnostic Feature Thyroid Eye Disease (TED) Idiopathic Orbital Inflammation (IOID) Bacterial Orbital Cellulitis

Onset Insidious, chronic progressive Acute, explosive over hours to days Acute, rapidly progressive over 24-48h

Pain Dull ache or painless; gaze ache Severe, excruciating, deep orbital pain Moderate-to-severe pain; tender proptosis

Laterality Bilateral (85-90%); can be asymmetrical Typically unilateral in adults Typically unilateral

Eyelid Signs Retraction (Dalrymple), lid lag Inflammatory ptosis, erythema, oedema Marked inflammatory erythema, warmth, oedema

Muscle Involvement Often belly enlargement; tendons usually relatively spared Single or multiple muscles; tendon involvement can support the diagnosis Diffuse phlegmon; muscles displaced/infiltrated

CT/MRI Findings Fusiform belly expansion; clear fat/tendons Ragged muscle; tendon involved; fat stranding Sinus opacification (ethmoid); SPA; abscess

Steroid Response Depends on activity and treatment Can improve rapidly, but response is not diagnostic and may be incomplete Never substitute a steroid trial for prompt antimicrobial treatment and source control

Underlying Etiology Autoimmune anti-TSH-R / IGF-1R cross-talk Non-specific fibro-inflammatory / idiopathic Bacterial infection ( S. pneumoniae , S. aureus )

Orbital Infection and Inflammation Safety

New RAPD, visual loss, severe restriction, proptosis or neurological signs require urgent orbital/ENT assessment and imaging. Subperiosteal-abscess drainage depends on vision, age, site/size, intracranial risk, progression and response, rather than an absolute age-nine rule. Use IV antibiotics selected by likely source, resistance and allergy and coordinate sinus source control. Chemosis alone does not establish orbital infection. IOI is a diagnosis of exclusion; response to steroids is not proof, since lymphoma can transiently improve. Atypical or recurrent lesions may require tissue before steroids where feasible, with infection and malignancy assessed first.